As the world moves toward a tokenized and decentralized future, dHealth has strategically positioned itself to be at the forefront of this transformation within the healthcare sector. Working alongside some of the most prominent organizations in the industry, with Eli Lilly, Roche and Novartis part of the roster, dHealth is shaping a future where healthcare is more efficient, transparent, and above all— places patients at the heart of care.
dHealth doesn’t just stand out as an innovative Web3 start-up, but also carries its weight within the healthcare space, where long-standing partnerships with leading pharmaceutical companies and healthcare-focused organizations play a key role in setting dHealth apart from other blockchain healthcare startups.
In an industry rife with barriers and red tape, these partnerships are not just strategic, but also imperative for the actualization of blockchain's utilization in reducing burgeoning healthcare costs across the globe.
Let’s delve into the specifics of how dHealth's partnerships are driving this incumbent paradigm shift within the healthcare economy.
Roche is the third-largest pharmaceutical company in the world - a towering presence, particularly in diagnostics and pharmaceuticals. With over 30 medicines listed in the World Health Organization's Model Lists of Essential Medicines, Roche’s commitment to global health is unparalleled.
The collaboration between dHealth and Roche is multifaceted, addressing treatment monitoring, blockchain-based COVID antibody certificates, and digital identity solutions to enhance data accuracy and security.
What's noteworthy is Roche's involvement in dHealth’s network through the maintenance of a Validator Node, underscoring their vested interest in the blockchain's transformative potential.
Roche utilized dHealth’s blockchain-based application CENTIVA designed to revolutionize treatment monitoring for conditions like hemophilia and spinal muscular atrophy.
The initiative had to be put on hold due to the prevailing geopolitical climate in Ukraine, as that’s where the pilot project was deployed, but the foundation for a decentralized healthcare paradigm has been laid. The treatment monitoring project is planned to resume when conditions allow for it.
And it's not just about treatment monitoring. Together with Roche, we've created a digital identity solution, employed for the study of consent management, that provides a clear level of data integrity and security.
Additionally, as COVID-19 gripped the world, the need for tamper-proof COVID antibody certificates became evident. In response, our collaborative effort further yielded blockchain-based certificates, guaranteeing the validity of PCR test results.
Our newest partnership is with Switzerland's first web3 cannabis company—Green Consensus. The goal of the partnership is to disrupt the traditional landscape of healthcare data related to cannabis use. AI will be utilized to analyze usage data to provide comprehensive insights into the true risks and potential benefits of various cannabis products on user communities to inform further research and testing for medical and clinical cannabis use.
This feasibility primarily stems from the capabilities of our CENTIVA Life app, which facilitates the generation of extensive data by cannabis users, aligning perfectly with the dataset magnitude required for AI to unveil remarkable discoveries.
Tailoring cannabis products to the medicinal needs of each individual, to fostering the development of novel cannabis-related treatments with healthcare professionals. In this synergy, dHealth sees a future where individuals are empowered to manage their health proactively, contributing to monumental advancements in cannabis well-being.
This data-driven approach targets long-standing issues in cannabis healthcare: inefficiencies in data collection, skepticism over data integrity, and reluctance to share personal cannabis usage due to privacy concerns. Through the dHealth Protocol, Green Consensus offers a secure platform where individuals retain full ownership of their data, thereby eliminating the risks of data mishandling.
As the CENTIVA Life app has been in operation and consistently built upon for the last three years, we're not just theorizing the integration of blockchain into healthcare; we're putting it into practice. We're unlocking new pathways, setting the stage for a healthcare system that's as efficient as it is compassionate, thereby proving that in the web3 healthcare industry, the right partnerships make all the difference.
Stay tuned for more details as we continue to unveil how dHealth, in partnership with global leaders, is crafting a future where healthcare is not just a service but a well-orchestrated ecosystem.
When it comes to reimagining organ transplantation, OrganX finds itself at the forefront of this new technology. As a Swiss-based Non-Profit Health Organization, OrganX is relentless in its mission to modernize medical guidelines and support cutting-edge technologies, especially those not yet ready for market deployment.
Our strategic partnership with OrganX embodies the future—specifically, an AI-powered, blockchain-secured solid organ exchange. Operating on a nonprofit basis, this exchange strives to align the varied interests of stakeholders in the transplantation ecosystem, aiming to refine the efficiency, transparency, and security of the organ donation process.
Our collaboration is yielding the development of a fully virtualized and tokenized transplant ecosystem, grounded in trust.
A notable spin-off of this partnership is a blockchain-based Organ Donor Card. Co-developed with the Paris Transplant Group—an interdisciplinary gathering of healthcare experts—the card guarantees global accessibility, complete privacy, and absolute unforgeability of a person's decision on organ donation. By optimizing donor-recipient matching, the partnership seeks to enhance the survival rates of both implants and patients, providing a glimmer of hope in an often grim scenario.
Finally, dHealth is in talks with bioprinting companies on the Indian subcontinent to spearhead the next phase of organ donation and transplantation in one of the highest growth economies - this will be announced in the coming month.
Swiss Tropical and Public Health Institute
As a leading authority in international and public health, the Swiss Tropical and Public Health Institute (Swiss TPH) is committed to global health equity and high-quality healthcare for all.
Our collaboration with Swiss TPH is an illustration of what can be achieved when technology merges with public health acumen to address planetary healthcare challenges.
We've co-developed two pivotal initiatives thus far, one focused on rabies and another on COVID-19.
Blockrabies, one of our standout projects, is a visionary initiative aimed at achieving zero human rabies deaths in Africa.
By utilizing dHealth's blockchain technology, we've built a tracking system for the supply-chain routes of rabies post-exposure prophylaxis medication. This secure, transparent, and easily accessible data repository empowers all project stakeholders to monitor real-time developments related to vaccine transport, vaccine administration, and post-vaccination health status—potentially averting tragedies related to rabies.
Given its effectiveness, this system is destined for institutionalization across Western Africa by 2024, with Ivory Coast and Mali being our pilot countries dHealth is currently operating in.
On the pandemic front, our collaboration also spawned a COVID-19 tracking module.
Developed in a public-private partnership alongside Novartis and the University of Basel, this tool enables real-time symptom reporting and swift contact tracing. Its adaptable architecture signifies that it could be repurposed for tracking other infectious diseases in the future.
Through our partnership with Swiss TPH, we're not just responding to current global health challenges but also laying the groundwork for more resilient, adaptive healthcare systems of the future. These partnerships are testaments to the limitless potential when technological innovation intersects with deep-seated expertise in international public health.
In a world shifting steadily towards a decentralized model, the REDCap Consortium emerges as a critical ally for dHealth. The Consortium, a collective centered on enhancing clinical and translational research through cutting-edge data management solutions, echoes our vision for innovation.
This collaboration has led to the seamless integration of Centiva Life Application with REDCap's secure web-based platforms. In a healthcare landscape often bottlenecked by legacy systems, the fusion of dHealth's blockchain capabilities with REDCap's robust data management services represents an inflection point.
It sets the pace for a revolution—increasing efficacy, data security, and most critically, saving lives by making research more streamlined and actionable.
Bowhead Health epitomizes how decentralized technologies can empower patients to take control of their healthcare data. As experts in secure healthcare data management and individualized wellness solutions, Bowhead Health is a natural partner for dHealth.
We bolster their mission by providing decentralized monitoring tools, enhancing the company's already robust platform. The dHealth network functions as an accelerant in this partnership, fortifying Bowhead's platforms with an additional layer of expertise on blockchain security & functionality.
The University of Applied Sciences and Arts Northwestern Switzerland (FHNW) stands as a lighthouse in the realms of engineering, business, and health sciences.
dHealth's partnership with FHNW extends beyond mere academic platitudes—manifesting in a Validator Node run by the University. Moreover, the institution commits researchers, eager and equipped to delve into the blockchain technologies, to study the dHealth network.
By fostering a vibrant academic ecosystem for blockchain studies, this partnership ensures that we're not just looking at today's innovations but also seeding the technological revolutions of tomorrow.
Gifu University in Japan is not just an academic institution but a hub of multidisciplinary research, from medicine and engineering to agriculture. The University operates a Validator Node and is actively engaged in testing the dHealth Network for storing data and tracking biosamples.
It's not just about leveraging existing capabilities; this partnership aims to thrust forward the boundaries of what's possible in the realm of decentralized healthcare solutions.
Imagine the groundbreaking contributions Gifu University’s research could make when enhanced by the robustness and security of blockchain—another stride in the relentless pace towards a decentralized healthcare revolution.
HOPR's role in enhancing data protection and privacy on the Internet aligns squarely with dHealth’s mission. The organization's decentralized protocols offer unassailable solutions for secure data transmissions, an indispensable component for the future of healthcare data.
By operating a Validator Node, HOPR contributes to the network’s robustness while echoing the broader goal to create a decentralized, tokenized, and most importantly, secure ecosystem.
Located in Pune, India, MIT-ADT University is an emblem of balanced education, combining technological advancements with cultural enrichment. Their partnership with dHealth has culminated in the launch of our first dHealth Innovation Hub.
During two semesters in 2022 the university, together with dHealth sponsored its students to build on the dHealth blockchain.
By running a Validator Node, MIT-ADT does more than just secure the network; it incubates the very innovation that will drive the healthcare industry into the next phase of its decentralized evolution.
Eli Lilly is the 10th largest pharmaceutical company in the world by revenue, and it is headquartered in Indianapolis, USA. The healthcare giant has a particular focus on oncology, diabetes care, and neuroscience, and is a leading player in research and development
The partnership between Eli Lilly and dHealth adds another layer of credibility and network strength to dHealth. Functioning as a multiplier within its vast network, Eli Lilly is not just running a Validator Node—they're amplifying the core mission of dHealth.
This puts us one step closer towards realizing a global decentralized healthcare ecosystem that's prepared to tackle the challenges of today, and tomorrow.
Headquartered in Basel, Switzerland, Novartis is a global pharmaceutical giant that stands at the intersection of pioneering research and patient-focused solutions. With a presence in over 155 countries, Novartis is committed to leveraging innovative science to address some of the world’s most challenging healthcare issues.
Our partnership with Novartis was a monumental stride in managing SARS-CoV-2 outbreaks. The joint development of a COVID-19 module—realized in a Private-Public Partnership with University of Basel and Swiss TPH—stands as a testament to what collaborative efforts can achieve.
While the end of the pandemic has rendered the module's initial purpose moot, its flexible architecture allows it to be a potent tool for future diseases. This is not just problem-solving; it’s foresight in action.
In a world rapidly gravitating towards decentralized systems, each partnership is more than just a collaboration. They're steps in the grander journey towards a tokenized, transparent, and effective healthcare system. As the pace of blockchain adoption skyrockets, dHealth continues to be at the forefront—redefining healthcare, saving lives, and yes, creating immense value.
National Lung Hospital in Vietnam
The National Lung Hospital in Hanoi is a colossus in respiratory healthcare, handling thousands of cases annually. Specializing in pulmonary conditions, the hospital leverages advanced technologies and seasoned medical experts to provide unparalleled patient care.
This facility was among the first to collaborate with dHealth, initiating an extraordinary program centered around dHealth’s token called Digital Health Points (DHP), in 2019. The pilot project included the application of both DHP as an incentive mechanism and the dHealth’s CENTIVA Life app for data collection—with the ultimate aim of encouraging treatment adherence in tuberculosis patients.
Not only did this enhance treatment compliance but it also amplified the patient data, enriching the hospital’s reservoir of knowledge for more precise patient treatment and care.
The project was originally intended to include 5,000 Tuberculosis patients at the NLH annually. In parallel, data collection was extended to patients suffering from different respiratory diseases
Although disrupted by the pandemic, the promising program is poised to resume, breathing new life into how blockchain technology can improve patient outcomes.
The European and Developing Countries Clinical Trials Partnership (EDCTP) serves as an engine driving medical research and innovation, especially for diseases affecting vulnerable populations.
EDCTP’s involvement in the Blockrabies project is emblematic of the organization's commitment to hasten clinical trials and build capacity. The sponsorship of the Blockrabies project signals a move towards the integration of blockchain technology in streamlining medical research, as well as providing the best possible healthcare service.
The University of Zurich Blockchain Center
As an epicenter of blockchain expertise, the University of Zurich Blockchain Center aims to weave academic rigor into the very fabric of this burgeoning technology. Beyond merely running a Validator Node, the Center also performed research on token migration during dHealth network launch, as well as performed research on the willingness of individuals and organizations to share data for incentives.
This demonstrates an alignment of scholarly pursuits with real-world applications, elevating the Center from a mere academic entity to an operational dynamo driving blockchain's future.
As our supporters and interested individuals cast their eyes upon the constellation of our partners, each contributing a unique facet to dHealth’s mission—a single narrative becomes evident: the decentralization of healthcare is not just inevitable; it’s already underway.
From esteemed academic institutions like FHNW University and the University of Zurich Blockchain Center, to industry giants like Eli Lilly, Roche and Novartis—each partnership brings us closer to the realization of a patient-centric decentralized global healthcare ecosystem.
The promise of blockchain in healthcare is no longer speculative; it's manifesting in the form of real-world applications that save lives, improve patient care, and, indeed—rewrite the rules of healthcare as we know it
Each of our partnerships does more than just contribute to the dHealth ecosystem; they amplify its capabilities and extend its reach, creating a synergistic force that is accelerating the advent of a decentralized, tokenized, and thoroughly transformative healthcare paradigm.
The world is rapidly gearing up for a decentralized tomorrow, and in this transformative period, dHealth and its partners are not merely participants but pioneers. Every day we are laying the foundations and setting the gold standard for what healthcare in a decentralized world should look like.
Indeed, the future of healthcare is not just being written; it’s being decentralized as well as tokenized - enabling retail investors to own a stake in the work that dHealth is doing.
Let’s make yesterday’s sci-fi concepts, today’s reality—together.